Megalencephaly and Macrocephaly

被引:27
作者
Winden, Kellen D. [1 ]
Yuskaitis, Christopher J. [2 ]
Poduri, Annapurna [2 ]
机构
[1] Boston Childrens Hosp, Dept Neurol, Boston, MA USA
[2] Boston Childrens Hosp, Dept Neurol, Div Epilepsy & Clin Electrophysiol, Epilepsy Genet Program, Boston, MA 02115 USA
关键词
megalencephaly; hemimegalencephaly; macrocephaly; somatic mutation; TUBEROUS SCLEROSIS COMPLEX; AUTISM SPECTRUM DISORDERS; OF-FUNCTION MUTATIONS; CAUSE NOONAN-SYNDROME; NEUROFIBROMATOSIS TYPE-1; CORTICAL DEVELOPMENT; MOLECULAR PATHOGENESIS; ACTIVATING MUTATIONS; GERMLINE MUTATIONS; CLINICAL-FEATURES;
D O I
10.1055/s-0035-1552622
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Megalencephaly is a developmental disorder characterized by brain overgrowth secondary to increased size and/or numbers of neurons and glia. These disorders can be divided into metabolic and developmental categories based on their molecular etiologies. Metabolic megalencephalies are mostly caused by genetic defects in cellular metabolism, whereas developmental megalencephalies have recently been shown to be caused by alterations in signaling pathways that regulate neuronal replication, growth, and migration. These disorders often lead to epilepsy, developmental disabilities, and behavioral problems; specific disorders have associations with overgrowth or abnormalities in other tissues. The molecular underpinnings of many of these disorders are now understood, providing insight into how dysregulation of critical pathways leads to disease. The advances in molecular understanding are leading to improved diagnosis of these conditions, as well as providing new avenues for therapeutic interventions.
引用
收藏
页码:277 / 287
页数:11
相关论文
共 84 条
[1]   Gain-of-Function Mutations in RIT1 Cause Noonan Syndrome, a RAS/MAPK Pathway Syndrome [J].
Aoki, Yoko ;
Niihori, Tetsuya ;
Banjo, Toshihiro ;
Okamoto, Nobuhiko ;
Mizuno, Seiji ;
Kurosawa, Kenji ;
Ogata, Tsutomu ;
Takada, Fumio ;
Yano, Michihiro ;
Ando, Toru ;
Hoshika, Tadataka ;
Barnett, Christopher ;
Ohashi, Hirofumi ;
Kawame, Hiroshi ;
Hasegawa, Tomonobu ;
Okutani, Takahiro ;
Nagashima, Tatsuo ;
Hasegawa, Satoshi ;
Funayama, Ryo ;
Nagashima, Takeshi ;
Nakayama, Keiko ;
Inoue, Shin-ichi ;
Watanabe, Yusuke ;
Ogura, Toshihiko ;
Matsubara, Yoichi .
AMERICAN JOURNAL OF HUMAN GENETICS, 2013, 93 (01) :173-180
[2]   Activating AKT2 Mutation: Hypoinsulinemic Hypoketotic Hypoglycemia [J].
Arya, Ved Bhushan ;
Flanagan, Sarah E. ;
Schober, Edith ;
Rami-Merhar, Birgit ;
Ellard, Sian ;
Hussain, Khalid .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (02) :391-394
[3]   Hemimegalencephaly, a paradigm for somatic postzygotic neurodevelopmental disorders [J].
Baek, Seung Tae ;
Gibbs, Elizabeth M. ;
Gleeson, Joseph G. ;
Mathern, Gary W. .
CURRENT OPINION IN NEUROLOGY, 2013, 26 (02) :122-127
[4]   A developmental and genetic classification for malformations of cortical development: update 2012 [J].
Barkovich, A. James ;
Guerrini, Renzo ;
Kuzniecky, Ruben I. ;
Jackson, Graeme D. ;
Dobyns, William B. .
BRAIN, 2012, 135 :1348-1369
[5]   Canavan's spongiform leukodystrophy -: A clinical anatomy of a genetic metabolic CNS disease [J].
Baslow, MH .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2000, 15 (02) :61-69
[6]   mTOR cascade activation distinguishes tubers from focal cortical dysplasia [J].
Baybis, M ;
Yu, J ;
Lee, A ;
Golden, JA ;
Weiner, H ;
McKhann, G ;
Aronica, E ;
Crino, PB .
ANNALS OF NEUROLOGY, 2004, 56 (04) :478-487
[7]   Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants [J].
Bennett, MR ;
Rizvi, TA ;
Karyala, S ;
McKinnon, RD ;
Ratner, N .
JOURNAL OF NEUROSCIENCE, 2003, 23 (18) :7207-7217
[8]   Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype [J].
Brems, Hilde ;
Chmara, Magdalena ;
Sahbatou, Mourad ;
Denayer, Ellen ;
Taniguchi, Koji ;
Kato, Reiko ;
Somers, Riet ;
Messiaen, Ludwine ;
De Schepper, Sofie ;
Fryns, Jean-Pierre ;
Cools, Jan ;
Marynen, Peter ;
Thomas, Gilles ;
Yoshimura, Akihiko ;
Legius, Eric .
NATURE GENETICS, 2007, 39 (09) :1120-1126
[9]   The genomically mosaic brain: Aneuploidy and more in neural diversity and disease [J].
Bushman, Diane M. ;
Chun, Jerold .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2013, 24 (04) :357-369
[10]   Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations [J].
Butler, MG ;
Dasouki, MJ ;
Zhou, XP ;
Talebizadeh, Z ;
Brown, M ;
Takahashi, TN ;
Miles, JH ;
Wang, CH ;
Stratton, R ;
Pilarski, R ;
Eng, C .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (04) :318-321